Skip to main content

American Oncology Network Presents 15 Research Abstracts at ASCO Quality 2025

FORT MYERS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) — American Oncology Network (AON), one of the fastest-growing community oncology networks in the nation, announced today that 15 research abstracts by AON physicians and leaders have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Quality Care Symposium 2025. The event, themed Driving Solutions, Implementing Change, takes place Oct. 10-11 in Chicago.

AON leaders will present on a variety of topics including the Inflation Reduction Act’s influence on Enhancing Oncology Model (EOM) Part D expenditures and total cost of care (Abstract #2) and Inflation’s Toll on Oncology Physician Reimbursement (Abstract #21).

13550_AON_ASCO-2025_Press-Release_Headshots_251007_V2 (5)

A full list of AON physician and leader abstracts at the ASCO Quality Care Symposium include:

“It is an honor to share our research and latest findings with peers at ASCO’s Quality Care Symposium,” said Puneeth Indurlal, MD, AON’s senior vice president of strategic operations and co-author on all abstracts. “ASCO symposiums foster collaboration, innovation, and the advancement of clinical oncology. Our participation reflects our ongoing commitment to improving cancer care through evidence-based practices.”

“These studies – many in collaboration with our value-based care partner, Thyme Care – demonstrate the powerful combination of real-world clinical data and robust technology to harness it for the creation of value-based insights that will be used to improve community oncology today and tomorrow,” said Dr. Stephen “Fred” Divers, AON’s chief medical officer and co-author on all abstracts.

“Having so many AON physicians and leaders featured at ASCO’s Quality Care Symposium speaks volumes about the caliber of talent across our network,” said Todd Schonherz, AON’s chief executive officer and co-author on many abstracts. “We are proud that AON’s culture of innovation and learning is supporting ASCO in advancing the field of oncology.”

For more information about AON, visit AONcology.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedInFacebookX (formerly Twitter) and YouTube.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e97c9075-d1da-4e1f-ac14-11bb6549605d

CONTACT: Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.